Sanofi: raises FY EPS target
(CercleFinance.com) - Sanofi announces that it has increased its business EPS growth forecast for FY 2020, now anticipating growth of 7%-8% at constant exchange rates (CER), barring major unforeseen adverse events.
The group reported Q3 business net income of 2,299 million euros, up 1% as reported and up 9.4% at constant exchange rates, representing business EPS of 1.83 euro, up 0.5% as reported and up 8.8% at constant exchange rates.
Sanofi generated quarterly net sales of 9,479 million euros, up 5.7% at constant exchange rates (down 0.2% on a reported basis), with sales growth driven by strong demand for Dupixent and influenza vaccines.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The group reported Q3 business net income of 2,299 million euros, up 1% as reported and up 9.4% at constant exchange rates, representing business EPS of 1.83 euro, up 0.5% as reported and up 8.8% at constant exchange rates.
Sanofi generated quarterly net sales of 9,479 million euros, up 5.7% at constant exchange rates (down 0.2% on a reported basis), with sales growth driven by strong demand for Dupixent and influenza vaccines.
Copyright (c) 2020 CercleFinance.com. All rights reserved.